HeartSciences (HSCSW) Shareholder's Equity Growth (1y) (2022 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | HeartSciences | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 48.44% |
| Oct 31, 2025 | 4.13% |
| Jul 31, 2025 | -47.07% |
| Apr 30, 2025 | -97.20% |
| Jan 31, 2025 | -79.31% |
| Oct 31, 2024 | 343.48% |
| Jul 31, 2024 | 1,241.80% |
| Apr 30, 2024 | 3,073.75% |
| Jan 31, 2024 | 3,447.59% |
| Oct 31, 2023 | -252.37% |
| Jul 31, 2023 | -118.00% |
| Apr 30, 2023 | 103.81% |
| Jan 31, 2023 | 93.71% |
| Oct 31, 2022 | 131.45% |
| Jul 31, 2022 | 219.89% |